THC
Income statement / Annual
Last year (2023), Tenet Healthcare Corporation's total revenue was $20.55 B,
an increase of 7.17% from the previous year.
In 2023, Tenet Healthcare Corporation's net income was $611.00 M.
See Tenet Healthcare Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$20.55 B
|
$19.17 B
|
$19.49 B
|
$17.64 B
|
$18.48 B
|
$18.31 B
|
$19.18 B
|
$19.62 B
|
$18.63 B
|
$16.62 B
|
| Cost of Revenue |
$18.12 B |
$3.27 B |
$3.33 B |
$2.98 B |
$3.06 B |
$3.00 B |
$3.09 B |
$3.12 B |
$2.96 B |
$2.63 B |
| Gross Profit |
$2.43 B |
$15.90 B |
$16.16 B |
$14.66 B |
$15.42 B |
$15.31 B |
$16.09 B |
$16.50 B |
$15.67 B |
$13.99 B |
| Gross Profit Ratio |
0.12 |
0.83 |
0.83 |
0.83 |
0.83 |
0.84 |
0.84 |
0.84 |
0.84 |
0.84 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$9.15 B
|
$8.84 B
|
$8.88 B
|
$8.42 B
|
$8.70 B
|
$8.63 B
|
$9.27 B
|
$9.36 B
|
$9.01 B
|
$8.02 B
|
| Selling & Marketing
Expenses |
-$8.73 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$418.00 M
|
$8.84 B
|
$8.88 B
|
$8.42 B
|
$8.70 B
|
$8.63 B
|
$9.27 B
|
$9.36 B
|
$9.01 B
|
$8.02 B
|
| Other Expenses |
$4.88 B |
$4.65 B |
$4.87 B |
$4.10 B |
$5.04 B |
-$5.00 M |
-$22.00 M |
$5.71 B |
$5.28 B |
$4.86 B |
| Operating Expenses |
$4.38 B |
$13.49 B |
$13.75 B |
$12.52 B |
$13.74 B |
$13.69 B |
$14.71 B |
$15.07 B |
$14.29 B |
$12.88 B |
| Cost And Expenses |
$18.04 B |
$16.76 B |
$17.08 B |
$15.50 B |
$16.80 B |
$16.70 B |
$17.79 B |
$18.19 B |
$17.25 B |
$15.51 B |
| Interest Income |
$0.00 |
$890.00 M |
$923.00 M |
$1.00 B |
$985.00 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$901.00 M |
$890.00 M |
$923.00 M |
$1.00 B |
$985.00 M |
$1.00 B |
$1.03 B |
$979.00 M |
$912.00 M |
$754.00 M |
| Depreciation &
Amortization |
$870.00 M
|
$841.00 M
|
$855.00 M
|
$857.00 M
|
$850.00 M
|
$802.00 M
|
$870.00 M
|
$850.00 M
|
$797.00 M
|
$849.00 M
|
| EBITDA |
$3.66 B
|
$3.33 B
|
$3.42 B
|
$2.43 B
|
$2.90 B
|
$2.79 B
|
$2.54 B
|
$2.56 B
|
$2.20 B
|
$1.94 B
|
| EBITDA Ratio |
0.18 |
0.18 |
0.18 |
0.18 |
0.15 |
0.14 |
0.12 |
0.12 |
0.12 |
0.12 |
| Operating Income Ratio
|
0.12
|
0.12
|
0.15
|
0.11
|
0.08
|
0.09
|
0.06
|
0.06
|
0.06
|
0.06
|
| Total Other
Income/Expenses Net |
-$893.00 M
|
-$989.00 M
|
-$983.00 M
|
-$1.32 B
|
-$1.22 B
|
-$1.01 B
|
-$1.21 B
|
-$999.00 M
|
-$933.00 M
|
-$778.00 M
|
| Income Before Tax |
$1.62 B |
$1.34 B |
$1.89 B |
$671.00 M |
$296.00 M |
$639.00 M |
-$101.00 M |
$248.00 M |
$144.00 M |
$147.00 M |
| Income Before Tax Ratio
|
0.08
|
0.07
|
0.1
|
0.04
|
0.02
|
0.03
|
-0.01
|
0.01
|
0.01
|
0.01
|
| Income Tax Expense |
$306.00 M |
$344.00 M |
$411.00 M |
-$97.00 M |
$153.00 M |
$176.00 M |
$219.00 M |
$67.00 M |
$68.00 M |
$49.00 M |
| Net Income |
$611.00 M |
$1.00 B |
$1.48 B |
$768.00 M |
$143.00 M |
$111.00 M |
-$704.00 M |
-$192.00 M |
-$140.00 M |
$12.00 M |
| Net Income Ratio |
0.03 |
0.05 |
0.08 |
0.04 |
0.01 |
0.01 |
-0.04 |
-0.01 |
-0.01 |
0 |
| EPS |
5.88 |
9.35 |
13.83 |
7.31 |
1.38 |
1.09 |
-7 |
-1.93 |
-1.41 |
0.12 |
| EPS Diluted |
5.71 |
9.05 |
13.6 |
7.23 |
1.38 |
1.07 |
-7 |
-1.93 |
-1.41 |
0.12 |
| Weighted Average Shares
Out |
$101.64 M
|
$106.93 M
|
$106.83 M
|
$105.01 M
|
$103.40 M
|
$102.11 M
|
$100.57 M
|
$99.32 M
|
$99.17 M
|
$97.80 M
|
| Weighted Average Shares
Out Diluted |
$104.80 M
|
$110.52 M
|
$108.57 M
|
$106.26 M
|
$103.40 M
|
$103.88 M
|
$100.59 M
|
$99.32 M
|
$99.17 M
|
$100.29 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
